Diasome
Developer of novel and cell-targeted therapies designed to treat diabetes, obesity, and other metabolic conditions. The company's therapies leverage technology, an insulin additive, to lessen the inst...
Valuation
$0
Share Price
N/A
Total Raised
$89.7M
Last Round
N/A